The Effect of Obesity on the α-Cell Response to Hyperglycemia in the Presence of Amino Acids
Hyperglycemia in prediabetes is accompanied by increased amino acid (AA) concentrations and impaired suppression of glucagon secretion by glucose. It is unknown whether an abnormal response to AA contributes or hepatic steatosis exacerbates α-cell dysfunction. Therefore, lean participants and participants with obesity (with and without hepatic steatosis) were studied on two occasions in random order using a graded glucose infusion. Saline or an AA mixture was infused. The glucagon secretion rate (GSR) was derived from peripheral glucagon concentrations, and the change in glucose required to reduce GSR by 50% (G50) was calculated for each participant. AAs were measured during the experiment. On both occasions, experimental conditions produced a progressive rise in insulin secretion and an inverse exponential suppression of glucagon. G50 did not differ between groups in response to glucose alone. AA infusion did not change G50 in lean participants. G50 increased during AA infusion in participants with obesity with and without hepatic steatosis, leading us to report these participants as a single group. The relative change in AA concentrations across study days was generally similar between groups. We conclude that despite a normal response to glucose, obesity increases α-cell responses to AA in humans. Article Highlights The aim of this study was to understand the pathogenesis of α-cell dysfunction in prediabetes. The primary hypothesis was that α-cell responsivity to glucose (reduction of the glucagon secretion rate by 50%) is impaired by amino acid (AA) infusion. A secondary hypothesis was that this abnormal response is exacerbated by hepatic steatosis. AA infusion impaired α-cell suppression in response to rising glucose in participants with obesity, but not in lean participants, despite a normal response to glucose alone. This abnormal response was unaffected by the presence or absence of hepatic steatosis. It seems likely that an abnormal α-cell response to AAs precedes an abnormal response to glucose alone.
Authors
- Michael D. Jensen (ORCID: https://orcid.org/0000-0001-5589-8389)
- Hannah E. Christie (ORCID: https://orcid.org/0000-0002-0606-6778)
- Francesca S. Boscolo (ORCID: https://orcid.org/0009-0003-0545-7288)
- Adrian Vella (ORCID: https://orcid.org/0000-0001-6493-7837)
- Kent R. Bailey (ORCID: https://orcid.org/0000-0001-8968-643X)
- Chiara Dalla Man (ORCID: https://orcid.org/0000-0002-4908-0596)
- Aoife M. Egan (ORCID: https://orcid.org/0000-0003-0379-9279)
- Sneha Mohan (ORCID: https://orcid.org/0000-0002-4840-1802)
- K. Sree Nair
Institutions
- Mayo Clinic (US)
- University of Padua (IT)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Diabetes
- Published
- 2026-09-11
- DOI
- https://doi.org/10.2337/db26-0502
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00